GFAP and Alzheimer disease: Plasma levels of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP), as biomarkers of neuronal injury and astrocyte reactivity, respectively, also show different profiles in AD and FTD [12,14].